https://www.marketscreener.com/quote/stock/TRANSITION-THERAPEUTICS-I-1412014/news/Transition-Therapeutics-Announces-Enrolment-Completion-of-ELND005-Phase-2-Clinical-Study-in-Agitat-19956043/?utm_source=telegram&utm_medium=social&utm_campaign=share